Collegium Pharmaceutical, Inc. Line of Credit Facility, Periodic Payment
Collegium Pharmaceutical, Inc. (COLL) reported Line of Credit Facility, Periodic Payment of $1.48 million for the 12-month period ending 2017-12-31, per its 10-Q filed 2018-11-08.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityPeriodicPayment · last filed 2019-02-27
| Period end | Line of Credit Facility, Periodic Payment | Line of Credit Facility, Periodic Payment 12 month |
|---|---|---|
| 2017-12-31 | $1.48M 10-K · filed 2019-02-27 | $1.48M 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |